Achilles Therapeutics plc — Operating Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/7ba62334-9fea-4603-b09d-6cd50a588d46/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-75.3M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-041615 |
| FY 2022 | $-78.4M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-006473 |
| FY 2021 | $-64.2M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-008077 |
| FY 2020 | $-33.7M | 2020-01-01 – 2020-12-31 | evidence 0001564590-22-008077 |
| FY 2019 | $-13.8M | 2019-01-01 – 2019-12-31 | evidence 0001564590-22-008077 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).